Japanese Aerospace & Defense Stock News

Setting the scene for Seiko Epson shares Seiko Epson (TSE:6724) has drawn investor attention after recent share price pressure, with the stock showing negative returns over the past month and past 3 months, prompting closer scrutiny of its current valuation. See our latest analysis for Seiko Epson. Zooming out, the recent 7 day and 1 month share price declines sit against a year to date share price return that is only slightly negative. The 1 year total shareholder return of a 17% decline...

Mitsubishi UFJ Financial Group (TSE:8306) has announced significant leadership changes at the senior executive level. Takuya Tanaka has been appointed Senior Managing Corporate Executive with responsibilities linked to commercial banking and wealth management. Yoshiaki Ueno has been appointed Managing Corporate Executive with a focus on corporate planning and group level management. These appointments mark a reshuffling of top roles that could influence group wide priorities and capital...

J.S.B.Co.Ltd (TSE:3480) opened Q1 2026 with revenue of ¥16.8b and basic EPS of ¥18.13, alongside trailing twelve month EPS of ¥285.67 on revenue of ¥77.6b. Over recent quarters the company has seen quarterly revenue move between ¥15.3b and ¥27.0b while basic EPS has ranged from a loss of ¥24.20 per share to a profit of ¥267.87 per share, giving investors a wide set of earnings outcomes to weigh against the current print. With trailing net profit margin at 7.8% compared with 7.3% a year...

Recent Performance Snapshot Toyota Motor (TSE:7203) has been trading under pressure recently, with the share price down about 2.8% on the day, 4.1% over the past week, and 9.0% over the past month. Despite that softer near term performance, the stock shows a 3.4% gain over the past 3 months, with longer term total returns of 26.8% over 1 year, 106.4% over 3 years, and 124.8% over 5 years. See our latest analysis for Toyota Motor. The recent 1 month share price decline sits against a much...

Pharma Foods International (TSE:2929) has just posted its Q2 2026 numbers, with revenue of ¥16.7 billion and basic EPS of ¥2.31, alongside net income of ¥67 million. Over the last six quarters, the company has seen quarterly revenue move between ¥14.6 billion and ¥18.4 billion. Basic EPS has swung from a loss of ¥65.50 to a gain of ¥51.59 before landing at the latest ¥2.31 print, which puts the spotlight firmly on how much of that top line is actually flowing through to shareholders. For...

Recent performance snapshot for Mitsubishi Electric Mitsubishi Electric (TSE:6503) has drawn attention after a mixed share price pattern, with a 6.3% decline over the past month contrasting with a 13.8% gain in the past 3 months. Over longer horizons, the stock shows a 94.3% total return over the past year, 2.8x over 3 years, and 2.5x over 5 years. This sets the backdrop for evaluating its current fundamentals. See our latest analysis for Mitsubishi Electric. While the 1 month share price...

Eternal Hospitality GroupLtd (TSE:3193) has posted its Q2 2026 numbers with revenue of ¥12.8 billion and basic EPS of ¥25.03, alongside net income of ¥288.78 million, giving investors a clear snapshot of mid year trading. The company has seen quarterly revenue move from ¥11.2 billion in Q2 2025 to ¥12.8 billion in Q2 2026, while basic EPS shifted from ¥28.28 to ¥25.03 over the same period, and investors will be weighing these trends against the latest margin picture and how efficiently those...

Maruzen CHI HoldingsLtd (TSE:3159) has wrapped up FY 2026 with fourth quarter revenue of ¥43.3b and basic EPS of ¥2.47, rounding out a year where quarterly revenue ranged between ¥43.1b and ¥49.3b and EPS moved from ¥17.29 in Q1 to ¥2.47 in Q4. Across the latest trailing twelve months, revenue came in at ¥185.1b with basic EPS of ¥36.03, which may encourage investors to focus less on headline growth stories and more on how the business is converting that top line into earnings. With trailing...

Kumiai Chemical Industry (TSE:4996) has opened fiscal 2026 with Q1 revenue of ¥46,707 million and basic EPS of ¥32.74, setting a fresh reference point after a volatile run of quarterly earnings. The company has seen revenue move from ¥43,381 million in Q1 2025 to ¥46,707 million in Q1 2026, while basic EPS shifted from ¥33.25 to ¥32.74 over the same periods. This gives investors a clean snapshot of the top and bottom line as they weigh how a thinner 2.5% trailing net margin and that prior...

Why HOYA is on investors’ radar today HOYA (TSE:7741) has attracted attention after recent share price moves, with the stock up over the past 3 years and 5 years while posting mixed returns over the past week and month. See our latest analysis for HOYA. At a share price of ¥27,765, HOYA’s recent 7 day and 30 day share price returns of 2.61% and 2.44% declines contrast with a stronger 90 day share price return of 16.2% and a 1 year total shareholder return of 61.74%. This suggests longer term...

GIGABYTE recently announced a collaboration with Capcom to promote the upcoming Resident Evil Requiem game through a themed custom PC giveaway and bundled monitor-game offers, while Capcom’s board approved director changes and new management roles effective April 1, 2026. Together, the gaming hardware tie-in and leadership reshuffle highlight how Capcom is leaning on flagship IP while refining its internal business focus. We’ll now examine how the Resident Evil Requiem collaboration with...

Wondering whether SoftBank Group's current share price actually lines up with its underlying value? This article walks through the numbers so you can see how the market is pricing the story. The stock closed at ¥3,578 after an 8.9% decline over the last 7 days, a 24.0% drop over 30 days and a 22.5% fall year to date, while the 1 year return sits at 83.4% and the 3 year return is very large at about 3x. These swings have come as SoftBank Group continues to be closely watched as a major...

Takeda Pharmaceutical stock snapshot Takeda Pharmaceutical (TSE:4502) has drawn investor attention after a period of steady trading, with its share price around ¥5,673 and multi year total returns along with recent revenue and net income figures in focus. See our latest analysis for Takeda Pharmaceutical. At around ¥5,673 per share, Takeda Pharmaceutical has delivered a 90 day share price return of 27.54%, while its 1 year total shareholder return of 33.82% points to building momentum beyond...

In early March 2026, Arrcus announced a collaboration with Fujitsu and 1Finity to combine FUJITSU-MONAKA Arm-based CPUs, ArcOS software-defined networking, and high-speed optical interconnects into a secure, energy-efficient infrastructure for distributed AI workloads from edge inference to large-scale training. This partnership highlights Fujitsu’s push to align compute, networking, and optical transport for emerging Physical and enterprise AI use cases such as smart factories, robotics,...

Why Marubeni’s Branford Castle deal matters for shareholders Marubeni (TSE:8002) has drawn investor attention after committing capital to Branford Castle Partners’ new flagship fund and agreeing to work alongside the firm to source and support global investment opportunities. See our latest analysis for Marubeni. The Branford Castle agreement lands while Marubeni’s share price sits at ¥5,591, with a 1 day share price return of 4.02% and 7 day return of 3.86%. However, the 30 day share price...

OMRON (TSE:6645) has released its SF2030 2nd Stage medium term plan, outlining a broad shift toward data driven operations. The plan highlights increased focus on industrial automation, healthcare, and targeted growth in Europe. This roadmap sets out multi year priorities for redirecting investment and reshaping the company’s business mix. OMRON, trading at ¥4,532.0, enters this new phase after a mixed share price record, with a 13.4% return year to date and a 3.5% return over 1 year,...

Furukawa Electric has announced extensive executive transfers, new duties, and board director candidates following its March 5 Board of Directors meeting, with many changes taking effect from April 1 and further transitions planned through June 26, 2026. The reshuffle concentrates leadership around key domains such as digital infrastructure components, automotive systems, and energy infrastructure, suggesting a sharpened focus on technology-driven and infrastructure-related businesses. Next,...

Toro Neurovascular previously announced that the U.S. FDA had granted 510(k) clearance for its Toro 88 Superbore Catheter, with Kaneka Medical America LLC leading the U.S. commercial launch following the device’s first successful clinical use by Dr. Satoshi Tateshima. This launch underscores Kaneka’s deeper involvement in the neurovascular device market, pairing Toro’s catheter technology with Kaneka’s established U.S. sales and clinical support network. We’ll now examine how Kaneka’s role...

In March 2026, Frontier Lithium announced it had signed a non-binding Memorandum of Understanding with Panasonic Energy and Mitsubishi to explore lithium hydroxide procurement and broader collaboration around the PAK Lithium Project in Ontario, aimed at supplying North America’s electric vehicle battery supply chain from 2030. A key insight is that Mitsubishi’s existing joint venture role in the PAK Lithium Project now sits within a wider potential offtake and technical cooperation framework...

In March 2026, Lasertec drew heightened attention after reports of stronger-than-expected order momentum for its semiconductor inspection and wafer metrology equipment, following a sharp sector-wide selloff tied to inflation concerns. This sequence of macro-driven weakness followed by renewed product-focused interest highlights how quickly sentiment can swing around Lasertec’s core inspection business. We’ll now examine how this stronger-than-expected order momentum for semiconductor...

If you are wondering whether Asahi Kasei is still good value after its recent run, you are not alone. The key question now is how the current share price lines up with the underlying business. The stock closed at ¥1,616.5, with returns of 13.8% year to date, 60.5% over 1 year, 94.7% over 3 years and 38.5% over 5 years, although it has seen a 5.6% decline over the last 7 days and a 6.9% decline over the last 30 days. Recent news coverage around Asahi Kasei has focused on its position in the...

Kyowa Kirin (TSE:4151) has moved to discontinue all clinical trials of rocatinlimab after a planned safety review highlighted malignancy concerns linked to OX40 pathway modulation, including confirmed and suspected Kaposi’s sarcoma cases. See our latest analysis for Kyowa Kirin. At a share price of ¥2,339, Kyowa Kirin has seen a 1-day share price return of 1.56% and a 7-day gain of 3.89%, compared with a weaker 30-day share price return of a 10.11% decline and a year-to-date share price...

Mitsubishi Heavy Industries group company Turboden America was previously selected by Tallgrass to supply three Waste Heat-to-Power ORC plants at gas compressor stations in Ohio and Indiana, each expected to deliver around 10 MW of clean electricity and qualify for Inflation Reduction Act Investment Tax Credit incentives. This contract expands Mitsubishi Heavy Industries’ waste-heat-to-power footprint in the U.S., adding to its clean, reliable baseload power portfolio while potentially...

Computer Engineering & Consulting (TSE:9692) has posted its FY 2026 results with fourth quarter revenue of ¥18.6b and basic EPS of ¥51.56, backed by net income of ¥1,609m. The company’s quarterly revenue moved from ¥14.99b in FY 2025 Q4 to ¥18.6b in FY 2026 Q4, while basic EPS in those periods went from ¥23.72 to ¥51.56. This highlights higher earnings that put more focus on how sustainably it can defend and build its margins. See our full analysis for Computer Engineering & Consulting. With...